THE HUMAN U5-220KD PROTEIN (HPRP8) FORMS A STABLE RNA-FREE COMPLEX WITH SEVERAL US-SPECIFIC PROTEINS, INCLUDING AN RNA UNWINDASE, A HOMOLOGOF RIBOSOMAL ELONGATION-FACTOR EF-2, AND A NOVEL WD-40 PROTEIN
T. Achsel et al., THE HUMAN U5-220KD PROTEIN (HPRP8) FORMS A STABLE RNA-FREE COMPLEX WITH SEVERAL US-SPECIFIC PROTEINS, INCLUDING AN RNA UNWINDASE, A HOMOLOGOF RIBOSOMAL ELONGATION-FACTOR EF-2, AND A NOVEL WD-40 PROTEIN, Molecular and cellular biology (Print), 18(11), 1998, pp. 6756-6766
The human small nuclear ribonucleoprotein (snRNP) U5 is biochemically
the most complex of the snRNP particles, containing not only the Sm co
re proteins but also 10 particle-specific proteins. Several of these p
roteins have sequence motifs which suggest that they participate in co
nformational changes of RNA and protein. Together, the specific protei
ns comprise 85% of the mass of the U5 snRNP particle. Therefore, prote
in-protein interactions should be highly important for both the archit
ecture and the function of this particle. We investigated protein-prot
ein interactions using both native and recombinant US-specific protein
s. Native U5 proteins were obtained by dissociation of U5 snRNP partic
les with the chaotropic salt sodium thiocyanate. A stable, RNA-free co
mplex containing the 116-kDa EF-2 homologue (116kD), the 200kD RNA unw
indase, the 220kD protein, which is the orthologue of the yeast Prp8p
protein, and the U5-40kD protein was detected by sedimentation analysi
s of the dissociated proteins. By cDNA cloning, we show that the 40kD
protein is a novel WD-40 repeat protein and is thus likely to mediate
regulated protein-protein interactions. Additional biochemical analyse
s demonstrated that the 220kD protein binds simultaneously to the 40-
and the 116kD proteins and probably also to the 200kD protein. Since t
he 220kD protein is also known to contact both the pre-mRNA and the U5
snRNA, it is in a position to relay the functional state of the splic
eosome to the other proteins in the complex and thus modulate their ac
tivity.